Friedman Franklin Stuart 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Jul 17, 2020
Insider Transaction Report
Form 4
Friedman Franklin Stuart
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-07-15$34.58/sh+723$25,001→ 723 totalExercise: $53.41Exp: 2030-07-15→ Common Stock (723 underlying)
Footnotes (1)
- [F1]These options were issued upon election by the director to receive his cash board retainer fee for the second half of 2020 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy and 362 shares will vest on September 30, 2020 and 361 shares will vest on December 31, 2020, subject to the director's continued service on the board of directors, provided that, all shares shall become fully vested upon a change in control of the Company.